Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Ansell Limited is a global manufacturer of personal protective equipment (PPE), operating primarily in the healthcare, industrial, and life sciences safety markets. The company designs, manufactures, and markets protective gloves and related safety solutions used to reduce workplace risks and prevent contamination. Its core revenue is driven by disposable and reusable hand protection products sold to hospitals, laboratories, industrial facilities, and professional workers worldwide.
Founded in Australia in 1905 as part of the Dunlop Rubber Company, Ansell evolved from a regional rubber manufacturer into a specialized global safety solutions provider. Over several decades, the company divested non-core businesses and refocused on PPE, particularly hand and body protection. This strategic shift positioned Ansell as a leading global supplier with a strong emphasis on product innovation, regulatory compliance, and mission-critical safety applications.
Business Operations
Ansell operates through three primary business segments: Healthcare Global Business Unit (GBU), Industrial Global Business Unit (GBU), and Life Sciences Global Business Unit (GBU). The Healthcare GBU supplies single-use and surgical gloves for hospitals and medical professionals. The Industrial GBU provides mechanical, chemical, and cut-resistant gloves for manufacturing, construction, and energy customers. The Life Sciences GBU serves pharmaceutical, biotechnology, and cleanroom environments with high-specification gloves and protective apparel.
The company generates revenue through direct sales to large institutional customers and distributors, supported by long-term supply agreements. Ansell controls a global manufacturing network, with facilities in Asia, Europe, and the Americas, and maintains proprietary material formulations and ergonomic glove technologies. Key subsidiaries include Ansell Healthcare LLC and Ansell Protective Products Inc., which support regional sales and distribution. The company does not rely heavily on joint ventures but emphasizes vertically integrated manufacturing and quality assurance.
Strategic Position & Investments
Ansell’s strategic direction centers on premiumization, innovation, and targeted acquisitions that expand its presence in high-growth, high-regulation safety markets. Growth initiatives focus on expanding chemical protection, cleanroom solutions, and value-added services such as safety assessments and training. The company has consistently invested in research and development to improve glove durability, comfort, and protection standards.
Notable acquisitions include Ringers Gloves, strengthening Ansell’s position in specialty industrial hand protection, and Primus Gloves and Digitcare, which enhanced its healthcare and surgical glove offerings. Ansell has also invested in emerging protective technologies and automation within its manufacturing footprint to improve cost efficiency and supply chain resilience. These investments align with long-term demand trends for workplace safety, infection prevention, and regulatory compliance.
Geographic Footprint
Ansell is headquartered in Australia, with global operations spanning North America, Europe, Asia-Pacific, Latin America, and parts of Africa. Manufacturing is concentrated in Malaysia, Thailand, Sri Lanka, Vietnam, and China, while distribution and sales offices are located in major end markets worldwide.
The company derives a significant portion of revenue from North America and Europe, reflecting strong demand from healthcare systems and industrial customers in those regions. Ansell’s international footprint allows it to balance cost-efficient manufacturing with proximity to customers, while its global supply chain provides resilience against regional disruptions.
Leadership & Governance
Ansell is led by an experienced executive team with a focus on operational discipline, innovation, and sustainable growth. The leadership emphasizes a strategy of protecting people while delivering long-term shareholder value through disciplined capital allocation and continuous improvement in safety solutions.
Key executives include:
- Neil Salmon – Managing Director & Chief Executive Officer
- Zubair Javeed – Chief Financial Officer
- Michael Ansell – President, Industrial Global Business Unit
- Elizabeth Jennings – President, Healthcare Global Business Unit
- Sandy Clark – President, Life Sciences Global Business Unit
The company operates under a board-led governance framework consistent with Australian Securities Exchange standards, with an emphasis on risk management, ethical conduct, and environmental, social, and governance accountability.